Cagrilintide/semaglutide
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
Novo Nordisk · Phase 3 · Completed · Enrollment 331
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema 2.4 mg/2.4 mg | Obesity or overweight | 2.4 mg | n/r | n/r | n/r |
| Semaglutide 2.4 mg | Obesity or overweight | 2.4 mg | n/r | n/r | n/r |